Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the biotech industry. This time, you get to discover 5 hand-picked metabolomics startups.
Global Startup Heat Map highlights 5 Top Metabolomics Startups out of 122
The insights of this data-driven analysis are derived from the Big Data & Artificial Intelligence-powered StartUs Insights Discovery Platform, covering 2.093.000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & relevant startups within a specific field in just a few clicks.
The Global Startup Heat Map below reveals the distribution of the 122 exemplary startups & scaleups we analyzed for this research. Further, it highlights 5 metabolomics startups that we hand-picked based on criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these 5 startups & scaleups in this report. For insights on the other 117 metabolomics solutions, get in touch.
Million Marker enables Exposure Monitoring
Moving beyond genes and proteins, the BioTech industry is increasingly focusing on small molecules. Humans are constantly exposed to different environmental agents, such as pollution or workplace hazards. Changes in metabolites reflect exposure to these agents. This is why startups and scaleups leverage metabolomics for exposure monitoring solutions.
Million Marker is a US-based startup offering an exposure monitoring kit. The startup sends a urine sample collection kit, allowing the users to either mail it or schedule a pick-up. It then performs metabolomic analysis on the samples to measure individuals’ exposure to environmental toxins. Subsequent testing allows individuals to monitor changes in their exposomes over time.
Adapsyn develops Bacterial Metabolites
Bacteria are a source of many metabolites, such as antibiotics and pigments, that find applications across the BioTech industry. Bioprospecting startups advance this by looking for more novel metabolites in bacterial populations. Metabolomics, often in tandem with genomics and proteomics approaches, enables the discovery of novel metabolites. Integrating AI and automation makes the search process even more high-throughput and faster.
Canadian startup Adapsyn utilizes bioinformatics to develop novel bacterial metabolites for therapeutic applications. The startup’s platform mines metabolomic and genomic data to identify and isolate drug-like small molecules. Adapsyn’s metabolomic pipeline involves high-throughput high-resolution liquid chromatography, as well as chemical characterization and automated isolation of molecules. As a result, the startup helps pharma companies accelerate their small molecule drug discovery process.
Prometheus Metabolomics identifies Metabolic Biomarkers
Metabolic disorders lead to many diseases like metabolic syndrome, hypertension, and diabetes. Analysis of metabolites from samples provides insights into the pathophysiology of these diseases. Hence, biotech startups are developing diagnostics tests based on metabolomics. These analyze and quantify a large number of metabolites from body samples.
Prometheus Metabolomics is a British startup that provides a metabolic biomarkers service. The startup’s platform uses nuclear magnetic resonance (NMR) technology to identify biomarkers from biological samples. The technology helps develop novel metabolomics-based clinical diagnostic tests. This significantly increases the volume of data from a single experiment, in turn, improving the quality of medical data that can be extracted or predicted from a set of samples.
Afekta Technologies offers Phytochemical Analysis
Food items often contain plant-based ingredients that provide health benefits. However, it is hard to quantify them by traditional means. Moreover, food processing steps might alter their levels and erode the potential health benefits. Startups and scaleups employ metabolomics technologies to assess the presence of phytochemicals in processed food.
Finnish startup Afekta Technologies provides metabolomics-based phytochemical analysis. The startup’s solution, Fytovore, measures phytochemicals in food and beverages. It helps companies analyze the impact of processing on the health benefits of the food products, as well as facilitates the development of functional foods. The startup also provides metabolomics services for microbiota and biomedicine applications.
QuLab Medical provides Personalized Metabolic Profiling
Early detection of prediabetes helps patients take preventive actions, thereby preventing the onset of diabetes. However, most prediabetic patients are undiagnosed. Continuous monitoring of metabolites helps detect the progression of diseases like diabetes even before any symptoms show up. To address this, startups are combining metabolomics approaches with continuous monitoring solutions.
Israeli digital health startup QuLab Medical enables personalized metabolic profiling. The startup develops a small, minimally invasive patch that provides continuous metabolic data. It utilizes proprietary nanosensing technology, microelectromechanical systems (MEMS), and data science to predict and prevent multiple diseases. It helps both diabetic and prediabetic people monitor their sugar levels.
Discover more BioTech startups
Metabolomics startups, such as the 5 examples highlighted in this report, focus on metabolic biomarkers and profiling, as well as exposure monitoring and phytochemical analysis solutions. While all of these technologies play a major role in advancing metabolic disease management, they only represent the tip of the iceberg. To explore more omics technologies, simply get in touch to let us look into your areas of interest. For a more general overview, you can download our free BioTech Innovation Report to save your time and improve strategic decision-making.